These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25015109)

  • 1. A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis.
    Shen N; Yan F; Pang J; Wu LC; Al-Kali A; Litzow MR; Liu S
    Oncotarget; 2014 Jul; 5(14):5494-509. PubMed ID: 25015109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of Receptor Tyrosine Kinases Reverts Aberrant DNA Methylation in Acute Myeloid Leukemia.
    Shen N; Yan F; Pang J; Zhao N; Gangat N; Wu L; Bode AM; Al-Kali A; Litzow MR; Liu S
    Clin Cancer Res; 2017 Oct; 23(20):6254-6266. PubMed ID: 28720666
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeting epigenetic pathway with gold nanoparticles for acute myeloid leukemia therapy.
    Deng R; Shen N; Yang Y; Yu H; Xu S; Yang YW; Liu S; Meguellati K; Yan F
    Biomaterials; 2018 Jun; 167():80-90. PubMed ID: 29554483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin down-regulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia.
    Yu J; Peng Y; Wu LC; Xie Z; Deng Y; Hughes T; He S; Mo X; Chiu M; Wang QE; He X; Liu S; Grever MR; Chan KK; Liu Z
    PLoS One; 2013; 8(2):e55934. PubMed ID: 23457487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A vicious loop of fatty acid-binding protein 4 and DNA methyltransferase 1 promotes acute myeloid leukemia and acts as a therapeutic target.
    Yan F; Shen N; Pang JX; Zhao N; Zhang YW; Bode AM; Al-Kali A; Litzow MR; Li B; Liu SJ
    Leukemia; 2018 Apr; 32(4):865-873. PubMed ID: 28993705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid-binding protein FABP4 mechanistically links obesity with aggressive AML by enhancing aberrant DNA methylation in AML cells.
    Yan F; Shen N; Pang JX; Zhang YW; Rao EY; Bode AM; Al-Kali A; Zhang DE; Litzow MR; Li B; Liu SJ
    Leukemia; 2017 Jun; 31(6):1434-1442. PubMed ID: 27885273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary study on the role of miR‑148a and DNMT1 in the pathogenesis of acute myeloid leukemia.
    Wang XX; Zhang H; Li Y
    Mol Med Rep; 2019 Apr; 19(4):2943-2952. PubMed ID: 30720097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of NADPH oxidase NOX5-S, NF-κB, and DNMT1 in acid-induced p16 hypermethylation in Barrett's cells.
    Hong J; Li D; Wands J; Souza R; Cao W
    Am J Physiol Cell Physiol; 2013 Nov; 305(10):C1069-79. PubMed ID: 24025864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.
    Garzon R; Liu S; Fabbri M; Liu Z; Heaphy CE; Callegari E; Schwind S; Pang J; Yu J; Muthusamy N; Havelange V; Volinia S; Blum W; Rush LJ; Perrotti D; Andreeff M; Bloomfield CD; Byrd JC; Chan K; Wu LC; Croce CM; Marcucci G
    Blood; 2009 Jun; 113(25):6411-8. PubMed ID: 19211935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells.
    Soundararajan S; Wang L; Sridharan V; Chen W; Courtenay-Luck N; Jones D; Spicer EK; Fernandes DJ
    Mol Pharmacol; 2009 Nov; 76(5):984-91. PubMed ID: 19657047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia.
    Bi L; Zhou B; Li H; He L; Wang C; Wang Z; Zhu L; Chen M; Gao S
    BMC Cancer; 2018 Feb; 18(1):182. PubMed ID: 29439669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and Epigenetic Perturbations by DNMT3A-R882 Mutants Impaired Apoptosis through Augmentation of PRDX2 in Myeloid Leukemia Cells.
    Bera R; Chiu MC; Huang YJ; Liang DC; Lee YS; Shih LY
    Neoplasia; 2018 Nov; 20(11):1106-1120. PubMed ID: 30245403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia.
    Tagde A; Rajabi H; Stroopinsky D; Gali R; Alam M; Bouillez A; Kharbanda S; Stone R; Avigan D; Kufe D
    Oncotarget; 2016 Jun; 7(26):38974-38987. PubMed ID: 27259275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleolin Overexpression Confers Increased Sensitivity to the Anti-Nucleolin Aptamer, AS1411.
    Sharma VR; Thomas SD; Miller DM; Rezzoug F
    Cancer Invest; 2018; 36(9-10):475-491. PubMed ID: 30396283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-kappaB-dependent DNA methyltransferase activity in acute myeloid leukemia.
    Liu S; Liu Z; Xie Z; Pang J; Yu J; Lehmann E; Huynh L; Vukosavljevic T; Takeki M; Klisovic RB; Baiocchi RA; Blum W; Porcu P; Garzon R; Byrd JC; Perrotti D; Caligiuri MA; Chan KK; Wu LC; Marcucci G
    Blood; 2008 Feb; 111(4):2364-73. PubMed ID: 18083845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells.
    Suzuki M; Sunaga N; Shames DS; Toyooka S; Gazdar AF; Minna JD
    Cancer Res; 2004 May; 64(9):3137-43. PubMed ID: 15126351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation-mediated down-regulation of DNA methyltransferase-1 (DNMT1) is coincident with, but not essential for, global hypomethylation in human placenta.
    Novakovic B; Wong NC; Sibson M; Ng HK; Morley R; Manuelpillai U; Down T; Rakyan VK; Beck S; Hiendleder S; Roberts CT; Craig JM; Saffery R
    J Biol Chem; 2010 Mar; 285(13):9583-9593. PubMed ID: 20071334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ubiquitin-like with PHD and Ring Finger Domains 1 (UHRF1)/DNA Methyltransferase 1 (DNMT1) Axis Is a Primary Regulator of Cell Senescence.
    Jung HJ; Byun HO; Jee BA; Min S; Jeoun UW; Lee YK; Seo Y; Woo HG; Yoon G
    J Biol Chem; 2017 Mar; 292(9):3729-3739. PubMed ID: 28100769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RFTS-deleted DNMT1 enhances tumorigenicity with focal hypermethylation and global hypomethylation.
    Wu BK; Mei SC; Brenner C
    Cell Cycle; 2014; 13(20):3222-31. PubMed ID: 25485502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. δEF1 associates with DNMT1 and maintains DNA methylation of the E-cadherin promoter in breast cancer cells.
    Fukagawa A; Ishii H; Miyazawa K; Saitoh M
    Cancer Med; 2015 Jan; 4(1):125-35. PubMed ID: 25315069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.